The Magnificent Seven name that Sam Ruiz thinks is worth a miss

"Heading into 2025, I'd say that the landscape has become almost unanimously more optimistic," Ruiz says.

"High valuations, high optimism, good opportunities, but overarching all of that, I just think we have to recognise that it's something where there's little room for missteps or errors in the market. So you want to be very cautious about where you put your money," he adds.

So if caution is the mantra for 2025, where does Ruiz think the best opportunities still lie? Find out in this long-form interview as part of Livewire's 2025 Outlook Series. 

Some of the stocks he mentions include:

• A German company which he says is right in the "sweet spot" of the healthcare trade, 
• A life insurance company that trades more like a growth play than a value play,
• An under-the-radar industrial name, and:
• A Magnificent Seven stock he says will be disrupted rather than assisted by artificial intelligence - making it his stock to avoid for 2025.